Clinical Trial Update: Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan

View source ↗

Summary

The document reports the completed status of a clinical trial testing bosentan for thromboangiitis obliterans (Buerger's disease).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboangiitis Obliterans

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Hospital Universitario Getafe | Conditions: Thromboangiitis Obliterans | Status: COMPLETED